To explore the effects of interfering with mitochondrial dynamics on icKO-induced cardiac hypertrophy, the morphology and function of hearts treated with AAV-Drp1i and AAV-Mfn1 or the controls were further investigated (10 weeks after icKO; Figure 7A and 7B). Here, MFN1 is linked to cardiac hypertrophy.